Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ECYT > SEC Filings for ECYT > Form 8-K on 7-Nov-2013All Recent SEC Filings

Show all filings for ENDOCYTE INC

Form 8-K for ENDOCYTE INC


7-Nov-2013

Change in Directors or Principal Officers, Financial Statements and Exhibits


ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS

On November 7, 2013, the Board of Directors (the "Board") of Endocyte, Inc. (the "Company"), upon the recommendation of the Nominating and Corporate Governance Committee, elected Colin Goddard, Ph.D., to the Board, with a term to expire at the Company's 2014 annual meeting of stockholders. The appointment fills a directorship position on the Board created by the retirement of Douglas Bailey. Dr. Goddard has been appointed to the Compensation Committee, replacing Fred Middleton as a member of the Compensation Committee. There are no arrangements or understandings between Dr. Goddard and any other persons pursuant to which Dr. Goddard was selected as a director of the Company.

As a non-employee director, Dr. Goddard will participate in the non-employee director compensation arrangements described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on April 19, 2013.

A copy of the Company's press release announcing the appointment of Dr. Goddard to the Board is attached hereto as Exhibit 99.1, and the information set forth therein is incorporated herein by reference.



ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits

Exhibit No. Description

99.1 Press release dated November 7, 2013

Top of the Form

  Add ECYT to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ECYT - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.